Editorial: Bypassing the Biological Barriers by Means of Biocompatible Drug Delivery Systems.

Front Pharmacol

Department of Health Sciences, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", Catanzaro, Italy.

Published: November 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652143PMC
http://dx.doi.org/10.3389/fphar.2021.801383DOI Listing

Publication Analysis

Top Keywords

editorial bypassing
4
bypassing biological
4
biological barriers
4
barriers biocompatible
4
biocompatible drug
4
drug delivery
4
delivery systems
4
editorial
1
biological
1
barriers
1

Similar Publications

Open revascularization for infrainguinal peripheral arterial disease in elderly patients: A scoping review.

Semin Vasc Surg

September 2025

Division of Vascular and Endovascular Surgery, Department of Surgery, Northwell Health, Manhasset, NY; Zucker School of Medicine at Hofstra, Hempstead, NY. Electronic address:

Peripheral arterial disease (PAD) is a prevalent and debilitating condition in elderly patients, often leading to critical limb threatening ischemia (CLTI) and major amputations. While endovascular interventions are usually preferred for their lower perioperative risk, open surgical revascularization should also be considered due to its durability and superior patency in complex disease patterns. Age alone does not determine suitability for surgery; rather, candidacy hinges on frailty, functional status, comorbidities, and anatomical considerations.

View Article and Find Full Text PDF

Brain-computer interfaces (BCIs) represent an emerging advancement in rehabilitation, enabling direct communication between the brain and external devices to aid recovery in individuals with neurological impairments. BCIs can be classified into invasive, semi-invasive, non-invasive, or hybrid types. By interpreting neural signals and converting them into control commands, BCIs can bypass damaged pathways, offering therapeutic potential for conditions such as stroke, spinal cord injury, traumatic brain injury, and neurodegenerative diseases such as amyotrophic lateral sclerosis.

View Article and Find Full Text PDF